Sompraz%252525252525252525252525252525252525252525252525252520hp

# Sompraz%252525252525252525252525252525252525252525252525252520hp ## Overview Sompraz%252525252525252525252525252525252525252525252525252520hp (esomeprazole) is a proton pump inhibitor (PPI) that reduces gastric acid production. ## Primary Indications * Gastroesophageal reflux disease (GERD) - healing of erosive esophagitis and maintenance of healing. * Management of heartburn associated with GERD. * Healing of duodenal ulcers. * Reduction of risk of NSAID-associated gastric ulcers. * Part of a *Helicobacter pylori* eradication regimen. ## Adult Dosing * **Healing of Erosive Esophagitis:** 20 mg or 40 mg once daily for 4 to 8 weeks. * **Maintenance of Healing:** 20 mg once daily. * **GERD Symptom Management (Heartburn):** 20 mg once daily for up to 14 days. * **Duodenal Ulcer Healing:** 20 mg once daily for 4 weeks. * ***H. pylori* Eradication:** * 20 mg twice daily plus clarithromycin 500 mg twice daily and amoxicillin 1000 mg twice daily for 7 days. * 20 mg twice daily plus clarithromycin 500 mg twice daily and metronidazole 500 mg twice daily for 7 days. * **NSAID-Associated Gastric Ulcer Healing:** 20 mg or 40 mg once daily for 4 to 8 weeks. * **NSAID-Associated Gastric Ulcer Prevention:** 20 mg once daily. ## Pediatric Dosing Dosing varies significantly by indication and age. Consult specific pediatric guidelines or product labeling. * **GERD (1 to 11 years):** * Erosive esophagitis: 10 mg once daily for up to 8 weeks. * Maintenance of healing: 10 mg once daily. * **GERD (12 to 17 years):** * Erosive esophagitis: 20 mg or 40 mg once daily for up to 8 weeks. * Maintenance of healing: 20 mg once daily. ## Dose Adjustments * **Hepatic Impairment:** * Severe impairment: Maximum 20 mg once daily. * Moderate impairment: No dose adjustment typically needed, but caution is advised. * **Renal Impairment:** No dose adjustment required for mild to moderate impairment. Use with caution in severe impairment. ## Contraindications * Known hypersensitivity to esomeprazole, substituted benzimidazoles, or any component of the formulation. * Concomitant use with rilpivirine-containing HIV medications. ## Adverse Effects * **Common:** Headache, diarrhea, nausea, abdominal pain, constipation, flatulence. * **Serious:** *Clostridium difficile*-associated diarrhea, bone fractures (hip, wrist, spine), hypomagnesemia, vitamin B12 deficiency, lupus erythematosus, fundic gland polyps. ## Key Drug Interactions * **CYP2C19 and CYP3A4 Substrates:** Esomeprazole can increase concentrations of drugs metabolized by these enzymes (e.g., clopidogrel, voriconazole, certain antiretrovirals). * **Drugs Affected by Gastric pH:** Absorption of drugs requiring acidic gastric pH may be altered (e.g., ketoconazole, itraconazole, iron salts, vitamin B12). * **Rilpivirine:** Contraindicated due to increased risk of virologic failure. * **Methotrexate:** Concurrent use may increase methotrexate levels. ## Monitoring * Monitor for signs and symptoms of *C. difficile*-associated diarrhea. * Assess for bone fracture risk with long-term use. * Consider baseline and periodic monitoring of serum magnesium levels, especially with concurrent diuretic use or prolonged therapy (>1 year). * Monitor for signs of vitamin B12 deficiency with long-term use. ## Clinical Pearls * For *H. pylori* eradication, esomeprazole should be used in combination with antibiotics as directed. * Long-term PPI use is associated with increased risk of fractures, vitamin B12 deficiency, and hypomagnesemia. Consider risks and benefits for prolonged therapy. * Administer orally once daily, at least 1 hour before a meal. Delayed-release capsules/tablets can be swallowed whole or opened and mixed with applesauce. *** *This information is intended for healthcare professionals. Always consult the current official prescribing information and relevant clinical guidelines for complete details. Dosing may vary based on local protocols and individual patient factors.*